Clinical Trials in San Diego

Showing 10041-10060 of 12,589 trials

AqueSys Microfistula Implant in Refractory Glaucoma

NCT01640756

To establish the safety and performance of the AqueSys Microfistula Implant in eyes with refractory glaucoma.

AqueSys, Inc.60 participantsStarted Jul 2012

Fayetteville, Arkansas, United States • Los Angeles, California, United States • San Diego, California, United States +11 more locations

TERMINATEDPhase 3< 1 mile

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

NCT01190839

REMICADE (infliximab) is a drug used to treat active Crohn's disease and is being tested in an experiment to see if it may be useful in preventing relapse of Crohn's disease after surgical resection. This study will compare the effects (both good and bad) of REMICADE (infliximab) to those of placebo. Placebo looks like the drug being studied but has no active ingredients.

Crohn's Disease

Janssen Biotech, Inc.297 participantsStarted Nov 2010

Birmingham, Alabama, United States • La Jolla, California, United States • Orange, California, United States +139 more locations

AqueSys Microfistula Implant in Refractory Glaucoma

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

Find Trials by Condition in San Diego

Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

MD2Me - Texting to Promote Chronic Disease Management

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Trauma Equivalency Study of the CORA® and TEG® 5000 Systems

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma